RICKETTSIAL STIMULATION OF ENDOTHELIAL PLATELET-ACTIVATING-FACTOR SYNTHESIS

被引:12
|
作者
WALKER, TS [1 ]
MELLOTT, GE [1 ]
机构
[1] BALL STATE UNIV, DEPT BIOL, MUNCIE, IN 47306 USA
关键词
D O I
10.1128/IAI.61.5.2024-2029.1993
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Endothelial cells (EC) synthesize platelet-activating factor (PAF) when activated by agents such as ATP or thrombin, and PAF production occurs as a consequence of endothelial phospholipase A activity. Because interactions between Rickettsia prowazekii and a variety of host cells result in the expression of phospholipase A activity, we assessed the relative abilities of uninfected and rickettsia-infected EC to synthesize PAF. Endothelial cells were infected with rickettsiae and examined at 24-h intervals for rickettsial multiplication, EC viability, and PAF synthesis. By 24 h postinfection, 80% of the EC were infected with an average of 10.6 rickettsiae per cell; by 72 h, the rickettsiae were too numerous to count and the numbers of viable EC began to decrease. Both rickettsia-infected and sham-treated EC synthesized PAF when stimulated with either thrombin or ATP, but rickettsia-infected EC synthesized about three times as much PAF in response to cell activation as did their uninfected counterparts. Additionally, unlike their uninfected counterparts, rickettsia-infected EC synthesized significant amounts of PAF in the absence of cell activation; rickettsia-infected EC synthesized as much PAF in the absence of activation as did uninfected EC in response to ATP. In each case, essentially all of the newly synthesized PAF remained with the cell pellet. Finally, EC incubated with high numbers of rickettsiae (1,000 rickettsiae per EC) for 30 min synthesized more PAF when activated with ATP than did their sham-treated activated counterparts.
引用
收藏
页码:2024 / 2029
页数:6
相关论文
共 50 条
  • [31] ANTAGONISTS OF PLATELET-ACTIVATING-FACTOR
    TOKUMURA, A
    TSUKATANI, H
    SEIKAGAKU, 1985, 57 (12): : 1618 - 1623
  • [32] PLATELET-ACTIVATING-FACTOR ANTAGONISTS
    SAUNDERS, RN
    HANDLEY, DA
    ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1987, 27 : 237 - 255
  • [33] PLATELET-ACTIVATING-FACTOR RECEPTOR
    IZUMI, T
    TAKANO, T
    BITO, H
    NAKAMURA, M
    MUTOH, H
    HONDA, Z
    SHINIZU, T
    JOURNAL OF LIPID MEDIATORS AND CELL SIGNALLING, 1995, 12 (2-3): : 429 - 442
  • [34] THE PROMISE OF PLATELET-ACTIVATING-FACTOR
    BRAQUET, P
    MENCIAHUERTA, JM
    CHABRIER, PE
    TOUQUI, L
    VARGAFTIG, BB
    ISI ATLAS OF SCIENCE-PHARMACOLOGY, 1987, 1 (03): : 187 - 198
  • [35] PLATELET-ACTIVATING-FACTOR AND ISCHEMIA
    POTRON, G
    PETITFRERE, E
    NGUYEN, P
    CLINICAL HEMORHEOLOGY, 1993, 13 (02): : 155 - 176
  • [36] RADIOIMMUNOASSAY FOR PLATELET-ACTIVATING-FACTOR
    KARASAWA, K
    SATOH, N
    HONGO, T
    NAKAGAWA, Y
    SETAKA, M
    NOJIMA, S
    LIPIDS, 1991, 26 (12) : 1126 - 1129
  • [37] EFFECTS OF PLATELET-ACTIVATING-FACTOR RECEPTOR ANTAGONISTS ON INTRACELLULAR PLATELET-ACTIVATING-FACTOR FUNCTION IN NEUTROPHILS
    KOIKE, H
    IMANISHI, N
    NATSUME, Y
    MOROOKA, S
    EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION, 1994, 269 (03): : 299 - 309
  • [38] PLATELET-ACTIVATING-FACTOR INDUCED ISCHEMIC BOWEL NECROSIS - THE EFFECT OF PLATELET-ACTIVATING-FACTOR ACETYLHYDROLASE
    FURUKAWA, M
    LEE, EL
    JOHNSTON, JM
    PEDIATRIC RESEARCH, 1993, 34 (02) : 237 - 241
  • [39] HYDROGEN-PEROXIDE STIMULATES THE SYNTHESIS OF PLATELET-ACTIVATING-FACTOR BY PULMONARY ENDOTHELIAL-CELLS
    LEWIS, MS
    WHATLEY, RE
    MCINTYRE, TM
    PRESCOTT, SM
    ZIMMERMAN, GA
    CLINICAL RESEARCH, 1987, 35 (01): : A171 - A171
  • [40] HYDROGEN-PEROXIDE STIMULATES THE SYNTHESIS OF PLATELET-ACTIVATING-FACTOR BY PULMONARY ENDOTHELIAL-CELLS
    LEWIS, MS
    WHATLEY, RE
    MCINTYRE, TM
    PRESCOTT, SM
    ZIMMERMAN, GA
    CLINICAL RESEARCH, 1987, 35 (03): : A535 - A535